Blis Technologies Ltd operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Blis Technologies Ltd with three other pharmaceutical manufacturers in Australasia: Paradigm Biopharmaceuticals Ltd of AUSTRALIA (2020 sales of 4.70 million Australian Dollars [US$3.43 million] ), Pharmaust Limited of AUSTRALIA (4.12 million Australian Dollars [US$3.01 million] ), and Noxopharm Ltd which is also based in AUSTRALIA (8.34 million Australian Dollars [US$6.09 million] of which 100% was Clinical development).

Sales Analysis. During the year ended March of 2020, sales at Blis Technologies Ltd were 10.64 million New Zealand Dollars (US$7.21 million). This is an increase of 26.6% versus 2019, when the company's sales were 8.41 million New Zealand Dollars.